The
slide to be stained for PSA
comprised:
1. Appendix, 2. Kidney, 3. Prostate hyperplasia, 4 – 6. Prostate
adenocarcinoma.
(same tissue block as used for Prostein)
All tissues were fixed in 10% neutral buffered formalin.
Criteria for assessing a PSA staining as optimal included:
- A strong and distinct cytoplasmic
staining of virtually all the epithelial cells of the
hyperplastic prostate glands.
- A moderate to strong and distinct
cytoplasmic staining of virtually all the neoplastic cells of
the three prostate adenocarcinomas.
- No reaction of the epithelial cells in
the kidney and appendix.
- No more than a weak to moderate background reaction in
the vicinity of the positive prostate epithelial cells (antigen
diffusion).
126 laboratories participated in this
assessment. 76 % achieved a sufficient mark. In table 1 the
antibodies (Abs) used and marks are summarized.
Table 1.
Abs and
assessment marks
for PSA, run 27
|
Concentrated Abs |
N |
Vendor |
Optimal |
Good |
Borderl. |
Poor |
Suff.1 |
Suff. OPS2 |
|
mAb clone
ER-PR8 |
33 |
Dako |
14 |
11 |
7 |
1 |
76 % |
86 % |
|
mAb clone 35H9 |
8 |
Novocastra |
7 |
1 |
0 |
0 |
100 % |
100 % |
mAb clone cocktail
ER-PR8+PA05 |
4
1 |
NeoMarkers
Master Diagnostica |
2 |
1 |
2 |
0 |
60 % |
67 % |
mAb clone cocktail
ER-PR8+A67-B/E3 |
1 |
Biocare |
0 |
1 |
0 |
0 |
- |
- |
|
pAb A0562 |
44 |
Dako |
19 |
14 |
9 |
2 |
75 % |
82 % |
|
pAb RB-084 |
1 |
NeoMarkers |
0 |
0 |
1 |
0 |
- |
- |
|
Ready-To-Use Abs |
|
|
|
|
|
|
|
|
mAb clone ER-PR8,
760-4271 |
2
1 |
Ventana
Cell Marque |
1 |
0 |
2 |
0 |
- |
- |
mAb clone ER-PR8,
N1550 |
1 |
Dako |
0 |
0 |
0 |
1 |
- |
- |
|
mAb clone 35H9,
PA0431 |
2 |
Novocastra |
2 |
0 |
0 |
0 |
- |
- |
mAb clone cocktail
ER-PR8+A67-B/E3 |
1 |
Biocare |
0 |
0 |
1 |
0 |
- |
- |
|
pAb IS514/IR514 |
13 |
Dako |
9 |
3 |
1 |
0 |
92 % |
100 % |
|
pAb N1517 |
2 |
Dako |
1 |
1 |
0 |
0 |
- |
- |
|
pAb 760-2506 |
12 |
Ventana |
1 |
8 |
3 |
0 |
75 % |
100 % |
|
Total |
126 |
|
56 |
40 |
26 |
4 |
- |
- |
|
Proportion |
|
|
44 % |
32 % |
21 % |
3 % |
76 % |
- |
1) Proportion of sufficient stains
(optimal or good), 2) Proportion of sufficient stains with optimal
protocol settings only, see below.
Following central protocol parameters were used to obtain an optimal
staining:
Concentrated Abs
mAb clone ER-PR8: The protocols giving an optimal result were all
based on heat induced epitope retrieval (HIER) using either
Tris-EDTA/EGTA pH 9 (7/13)*, Target Retrieval Solution pH 9
(EnVision FLEX TRS high pH, Dako, (4/6), Bond Epitope Retrieval
Solution 2 (Bond, Leica) (1/1), EDTA/EGTA pH 8 (1/3) or Citrate pH
6 (1/4) as the retrieval buffer. The mAb was typically diluted in
the range of 1:50– 1:200 depending on the total sensitivity of the
protocol employed. Using these protocol settings 19 out of 22 (86 %)
laboratories produced a sufficient staining (optimal or good).
* (number of optimal results/number of laboratories using this
buffer)
mAb clone 35H9: The protocols giving an optimal result were all
based on heat induced epitope retrieval (HIER) using either
Tris-EDTA/EGTA pH 9 (3/3), Cell Conditioning 1 (BenchMark, Ventana)
(2/2), Bond Epitope Retrieval Solution 1 (Bond, Leica) (1/1) or
Citrate pH 6 (1/1) as the retrieval buffer. The mAb was typically
diluted in the range of 1:75– 1:600 depending on the total
sensitivity of the protocol employed. Using these protocol settings
7 out of 7 (100 %) laboratories produced a sufficient staining.
mAb clone cocktail ER-PR8+PA05: The protocols giving an optimal
result were all based on heat induced epitope retrieval (HIER) using
either Tris-EDTA/EGTA pH 9 (1/1) or EDTA/EGTA pH 8 (1/2) as the
retrieval buffer. The mAb was typically diluted in the range of
1:100– 1:200 depending on the total sensitivity of the protocol
employed. Using these protocol settings 2 out of 3 (67 %)
laboratories produced a sufficient staining.
pAb A0562: the protocols giving an optimal result were based either
or on heat induced epitope retrieval (HIER) or with omission of
retrieval. Using HIER a total of 11 out of 28 protocols resulted in
an optimal result using either Target Retrieval Solution pH 9
(EnVision FLEX TRS high pH, Dako, (8/15), Cell Conditioning 1
(BenchMark, Ventana) (1/3) or Citrate pH 6 (2/3) as the retrieval
buffer. With omission of epitope retrieval 8 out of 14 protocols
gave an optimal result. The pAb was typically diluted in the range of
1:1.000 – 1:6.000 without HIER and 1:3.000 – 15.000 when HIER was
applied. Using these protocol settings 28 out of 34 (82 %)
laboratories produced a sufficient staining.
Ready-To-Use Abs
mAb clone ER-PR8 (prod. no. 760-4271, Ventana/Cell Marque):
The protocol giving an optimal result was based on HIER using
standard Cell Conditioning 1 (BenchMark, Ventana), an
incubation time of 60 min in the primary Ab and Ultra View (760-500)
with amplification
kit as the detection system.
mAb clone 35H9 (prod.no. PA0431, Novocastra): The protocols giving
an optimal result were all based on HIER using Bond Epitope
Retrieval Solution 1 (Bond, Leica), an incubation time of 25 or 30
min in the primary Ab and BOND Polymer Refine Detection (DS9800) as
the detection system. Using these protocol settings both laboratories produced an
optimal staining.
pAb IS514/IR514 (Dako): The protocols giving an optimal result were
all based on HIER in PT-Link using Target Retrieval Solution pH 9
(EnVision FLEX TRS high pH), an incubation time of 20 min in the
primary Ab and EnVision Flex (K8000) or Flex+ (K8002) as the
detection system. Using these protocol settings 9 out of 9 (100 %)
laboratories produced a sufficient staining.
pAb N1517 (Dako): The protocol giving an optimal result were based
on HIER in PT-Link using Target Retrieval Solution pH 9 (EnVision
FLEX TRS high pH, 20min), an incubation time of 20 min in the
primary Ab (the RTU Ab was diluted 1:8) and EnVision Flex (K8000) as
the detection system. Using these protocol settings 1 out of 1
laboratory produced a sufficient staining.
pAb p 760-2506 (Ventana): The protocol giving an optimal result was
based on HIER using mild Cell Conditioning 1 (BenchMark, Ventana),
an incubation time of 32 min in the primary Ab and Ultra View
(760-500) as the detection system. Using this protocol setting 2 out
of 2 laboratories produced a sufficient staining.
The most frequent causes of insufficient stains were:
- Too low concentration of the primary antibody
- Insufficient heat induced epitope retrieval
- Too high concentration of the primary Ab – especially the pAb
A0562, Dako
- Use of a biotin based detection system (giving a false positive
reaction).
In this assessment the prevalent features of an insufficient
staining were either a weak/false negative reaction or a false
positive reaction in the tested specimens. A weak/false negative
reaction was seen in 60 % of the insufficient results and was mainly
caused by a too low concentration of the primary Ab and/or
insufficient HIER. In 40 % a false positive reaction was observed.
The false positive reaction was typically characterized by a
distinct reaction in the epithelial cells in the kidney but also in
lymphocytes in e.g., the appendix. The pattern was most frequently
seen, when the pAb A0562, Dako, was used relatively concentrated and
with HIER. However it has to be stressed that similar protocol
settings and using same primary Ab also resulted in optimal results
– suggesting a lot-to-lot variation of the pAb. It was also observed that HIER actually reduced the
background reaction in the prostate specimens compared to omission
of HIER for the pAb A0452, Dako.
Also the combination of HIER and a biotin based detection system
frequently gave a false positive reaction of endogenous biotin
primarily seen in the epithelial cells of the kidney but also in the
epithelial cells of the appendix.
In this assessment the mAb clone 34H9, Novocastra was the most
robust marker for PSA, as all 10/10 protocols using this clone
obtained a sufficient result.
Prostate and kidney was in this assessment found to be recommendable
controls for PSA: The epithelial cells of the prostate glands must
show an as strong as positive cytoplasmic reaction, while the
epithelial cells of the kidney must be negative. A weak to moderate
background reaction in the vicinity of the positive epithelial cells
in the prostate is expected and acceptable. In this
assessment it was seen, that a reduction of the sensitivity of the
applied protocols in order to eliminate this background reaction frequently
gave a too weak reaction in the carcinomas.
This was the second assessment of PSA in NordiQC, and the proportion
of sufficient results declined from 90 % in run 12, 2004 to 76 % in
the current run – see table 2. The lower pass rate is probably due
to more challenging tissue material circulated and many laboratories
participating for the first time.
Table 2:
Proportion of sufficient results for PSA in the two NordiQC runs
performed
| |
Run 12
2004 |
Run 27 2009 |
|
Participants, n= |
79 |
126 |
|
Sufficient results |
90 % |
76 % |
Conclusion
The mAbs clones 35H9, ER-PR-8, ER-PR8+PA05
and the pAbs A0562 Dako, IR514/IS514 Dako and 760-2506 Ventana could
be used to obtain an optimal staining. The epitope retrieval and
protocol settings have to be specifically tailored to each of the
clones/cocktails. Prostate hyperplasia is a recommended positive
control provided that the epithelial cells show an as strong as positive
cytoplasmic reaction (a weak to moderate background reaction is acceptable). Kidney is a recommended negative control, as no
staining reaction must be seen in the epithelial cells.
|